ApoB: the cholesterol number most UAE panels skip

If you have had a cholesterol test in the UAE, you almost certainly got total cholesterol, LDL, HDL and triglycerides. You almost certainly did not get apolipoprotein B, and yet ApoB is the number that cardiology guidelines now describe as the more accurate measure of the risk that cholesterol testing is supposed to find. This post explains what ApoB is, why it can disagree with LDL, and what to do with the result.

Cholesterol is cargo. ApoB counts the lorries.

Cholesterol does not float freely in blood. It travels inside particles called lipoproteins. A standard LDL result measures how much cholesterol is being carried in the LDL fraction. It does not tell you how many particles are carrying it.

That distinction matters because it is the particle, not the cholesterol inside it, that gets stuck in an artery wall and starts a plaque. Every particle that can do that, including LDL, VLDL, IDL and lipoprotein(a), carries exactly one molecule of apolipoprotein B on its surface. Measuring ApoB therefore counts those particles directly. More particles, more chances to lodge, more risk.

When LDL and ApoB disagree

For many people the two move together and LDL is a fair proxy. For a large minority they do not, and that minority is over-represented in the UAE.

The pattern is called discordance. Someone with insulin resistance, high triglycerides or abdominal weight tends to have many small, cholesterol-poor LDL particles. Their LDL cholesterol can look normal because each particle carries little, while their particle count, and their ApoB, is high. The standard test reassures them. The particle count does not.

The reverse also happens. A lean, fit person can have large LDL particles, a high LDL cholesterol reading, and a normal ApoB. They are told to worry about a number that is not doing much harm.

Given how common insulin resistance is among UAE adults, the first pattern is the one to watch for. It is the reason a lipid profile without ApoB can miss the person it was meant to catch.

What the guidelines say

The 2019 European Society of Cardiology and European Atherosclerosis Society guideline on dyslipidaemia recommends ApoB for risk assessment, particularly in people with high triglycerides, diabetes, obesity or very low LDL, and states it can be preferred to LDL as the primary measurement. Large analyses have found that when ApoB and LDL disagree, risk follows ApoB.

Reading your result

ApoB is reported in grams per litre or milligrams per decilitre. Ranges vary by laboratory and by the risk category a clinician places you in, but broadly:

• Below about 0.8 g/L (80 mg/dL) is where most guidelines place low risk in otherwise healthy adults.
• Around 1.0 g/L (100 mg/dL) is a common population median and a common treatment threshold.
• Above about 1.3 g/L (130 mg/dL) is considered high.

Clare shows ApoB next to LDL, non-HDL cholesterol, triglycerides and the ApoB to ApoA1 ratio, so a discordant pattern is visible at a glance rather than something you have to work out.

ApoB and lipoprotein(a)

Lipoprotein(a), or Lp(a), is an LDL-like particle whose level is set almost entirely by genetics. It carries ApoB, so it contributes to the ApoB count, but it is worth measuring on its own at least once in a lifetime because a high level changes how aggressively other risk factors should be managed. Around one in five people has an elevated Lp(a), and most never find out. It is in the Clare panel.

What moves ApoB

The same things that move LDL, with a few emphases.

• Weight and insulin sensitivity. Because discordance is driven by small dense LDL, improving insulin resistance often brings ApoB down more than LDL.
• Saturated fat. Reducing it lowers particle count in most people.
• Fibre. Soluble fibre from oats, legumes and psyllium has a small but consistent effect.
• Medication. Statins, ezetimibe and newer agents all lower ApoB. Whether any of them is appropriate is a decision for a doctor, informed by ApoB, Lp(a) and the rest of your profile.

Why a retest matters here

ApoB responds to change within weeks, which makes it a good marker to follow. A first panel sets the baseline. A second panel three to six months after a change in diet, weight or medication shows whether the particle count moved. A single reading tells you where you are. Two readings tell you where you are going.

The short version

LDL cholesterol measures cargo. ApoB counts the particles. When they disagree, believe ApoB. If you have never had it measured, it is worth doing once, alongside Lp(a), and then following it. Both are part of every Clare panel.